Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Codexis, Inc. is a biotechnology company that develops and manufactures enzymatic solutions for the pharmaceutical industry, particularly for therapeutics manufacturing. Their proprietary CodeEvolver technology platform enables the discovery and enhancement of novel enzymes, and they also offer the ECO Synthesis platform for scaled RNAi therapeutic manufacturing. Codexis operates globally, serving markets in North America, Europe, Asia, and beyond.
AI-generated summary. Not investment advice.